Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes

Alzheimer’s disease (AD) affects tens of millions of people worldwide. Despite the advances in understanding the disease, there is an increased urgency for pharmacological approaches able of impacting its onset and progression. With a multifactorial nature, high incidence and prevalence in later yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanciu, Gabriela Dumitrita, Rusu, Razvan Nicolae, Bild, Veronica, Filipiuc, Leontina Elena, Tamba, Bogdan-Ionel, Ababei, Daniela Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160780/
https://www.ncbi.nlm.nih.gov/pubmed/34069618
http://dx.doi.org/10.3390/biomedicines9050576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160780/
https://www.ncbi.nlm.nih.gov/pubmed/34069618
http://dx.doi.org/10.3390/biomedicines9050576

Ejemplares similares